Current treatment of choice for chronic hepatitis C infection
Authors:
- Tom Riley IiiTITom Riley Iii
- Ian R SchreibmanISIan R Schreibman
Open Access
- 1 January 2011
- journal article
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. 4, 11-18
Abstract
More than three million Americans have chronic hepatitis C infection, and the disease remains one of the most common blood-borne infections in the US. Treatment is focused on the chronic form of the disease, because the acute one tends to be self-limiting. In this article, we review the recent literature regarding the most effective therapy against hepatitis C infection, to confirm the current treatment of choice for the disease. We conclude that combination therapy with pegylated interferon and ribavirin remains the initial treatment of choice. New research focusing on adjuvant therapies, such as protease and polymerase inhibitors, has yielded early data that appear to be promising.Keywords
This publication has 29 references indexed in Scilit:
- Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled studyJournal of Antimicrobial Chemotherapy, 2010
- Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients†Hepatology, 2009
- A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE)Journal of Hepatology, 2006
- Treatment of chronic hepatitis C in HIV-positive individuals: Selection of candidatesJournal of Hepatology, 2005
- Peginterferon alfa-2b and ribavirin for treatment-refractory chronic hepatitis CJournal of Hepatology, 2005
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- Antiviral action of ribavirin in chronic hepatitis CGastroenterology, 2004
- NIH Consensus Statement on Management of Hepatitis C: 2002.2004
- Early Virologic Response to Treatment With Peginterferon Alfa–2B Plus Ribavirin in Patients With Chronic Hepatitis CHepatology, 2003